Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.
Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.
复制标题
人结直肠癌中MMPs表达及预后的综合分析
DOI:
10.3389/fonc.2021.771099
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Chen H
中科院分区:
文献类型:
--
作者:
Yu J;He Z;He X;Luo Z;Lian L;Wu B;Lan P;Chen H
Background Previous study implicated that genes of matrix metalloproteinase (MMP) family play an important role in tumor invasion, neoangiogenesis, and metastasis. However, the diverse expression patterns and prognostic values of 24 MMPs in colorectal cancer are yet to be analyzed. Methods In this study, by integrating public database and our data, we first investigated the expression levels and protein levels of MMPs in patients with colorectal cancer. Then, by using TCGA and GEO datasets, we evaluated the association of MMPs with clinicopathological parameters and prognosis of colorectal cancer. Finally, by using the cBioPortal online tool, we analyzed the alterations of MMPs and did the network and pathway analyses for MMPs and their nearby genes. Results We found that, MMP1, MMP3, MMP7, MMP9–MMP12, and MMP14 were consistently upregulated in public dataset and our samples. Whereas, MMP28 was consistently downregulated in public dataset and our samples. In the clinicopathological analyses, upregulated MMP11, MMP14, MMP16, MMP17, MMP19, and MMP23B were significantly associated with a higher tumor stage. In the survival analyses, upregulated MMP11, MMP14, MMP17, and MMP19 were significantly associated with a shorter progression-free survival (PFS) time and a shorter relapse-free (RFS) time. Discussion This study implied that MMP11, MMP14, MMP17, and MMP19 are potential targets of precision therapy for patients with colorectal cancer.
登录
查看更多内容
影响因子:
11.2
作者:
Papageorgis P;Cheng K;Ozturk S;Gong Y;Lambert AW;Abdolmaleky HM;Zhou JR;Thiagalingam S
通讯作者:
Thiagalingam S
影响因子:
11.2
作者:
Garg P;Sarma D;Jeppsson S;Patel NR;Gewirtz AT;Merlin D;Sitaraman SV
通讯作者:
Sitaraman SV
影响因子:
64.5
作者:
Liu J;Lichtenberg T;Hoadley KA;Poisson LM;Lazar AJ;Cherniack AD;Kovatich AJ;Benz CC;Levine DA;Lee AV;Omberg L;Wolf DM;Shriver CD;Thorsson V;Cancer Genome Atlas Research Network;Hu H
通讯作者:
Hu H
DOI:
10.1016/j.bbrc.2004.11.027
发表时间:
2005-01-14
影响因子:
3.1
作者:
Deng, H;Guo, RF;Lu, YY
通讯作者:
Lu, YY
影响因子:
4
作者:
Chen, Chen;Liu, Xiaoping;Li, Sheng
通讯作者:
Li, Sheng